Clinical, Echocardiographic, and Therapeutic Characteristics of Heart Failure in Patients with Preserved, Mid-Range, and Reduced Ejection Fraction: Future Directions

References

• Braunwald E. Shattuck lecture–cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med. 1997;337(19):1360–1369. doi:10.1056/NEJM199711063371906
   PubMed Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the heart failure society of America. Circulation. 2017;136(6):e137–e161. doi:10.1161/CIR.0000000000000509
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–2200. doi:10.1093/eurheartj/ehw128
   PubMed Web of Science ®Google Scholar
• Lee DS, Gona P, Vasan RS, et al. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation. 2009;119(24):3070–3077. doi:10.1161/CIRCULATIONAHA.108.815944
   PubMed Web of Science ®Google Scholar
• Alqahtani M, Alanazi T, Binsalih S, et al. Characteristics of Saudi patients with congestive heart failure and adherence to management guidelines in a tertiary hospital in Riyadh. Ann Saudi Med. 2012;32(6):583–587. doi:10.5144/0256-4947.2012.583
   PubMed Web of Science ®Google Scholar
• Alhabeeb W, Elasfar A, AlBackr H, et al. Clinical characteristics, management and outcomes of patients with chronic heart failure: results from the heart function assessment registry trial in Saudi Arabia (HEARTS-chronic). Int J Cardiol. 2017;235(235):94–99. doi:10.1016/j.ijcard.2017.02.087
   PubMed Web of Science ®Google Scholar
• Subki AH, Almalki MA, Butt NS, et al. Echocardiographic and clinical correlates of ejection fraction among 2000 patients with heart failure in Western Saudi Arabia. Int J Gen Med. 2020;13:281–288. doi:10.2147/IJGM.S251924
   PubMed Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147–e239.
   PubMed Web of Science ®Google Scholar
• Vandenbroucke JP, von EE, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4(10):e297. doi:10.1371/journal.pmed.0040297
   PubMed Web of Science ®Google Scholar
• Alem MM. Predictors of mortality in patients with chronic heart failure: is hyponatremia a useful clinical biomarker? Int J Gen Med. 2020;13:407–417. doi:10.2147/IJGM.S260256
   PubMed Web of Science ®Google Scholar
• Alem MM, Aldosari SR, Alkahmous AA, Obad AS, Fagir NM, Al-Ghamdi BS. Effect of long-term allopurinol therapy on left ventricular mass index in patients with ischemic heart disease; a cross-sectional study. Vasc Health Risk Manag. 2019;15:539–550. doi:10.2147/VHRM.S226009
   PubMed Web of Science ®Google Scholar
• Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1–39. doi:10.1016/j.echo.2014.10.003
   PubMed Web of Science ®Google Scholar
• Hillege HL, Nitsch D, Pfeffer MA, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006;113(5):671–678. doi:10.1161/CIRCULATIONAHA.105.580506
   PubMed Web of Science ®Google Scholar
• Lund LH, Claggett B, Liu J, et al. Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum. Eur J Heart Fail. 2018;20(8):1230–1239. doi:10.1002/ejhf.1149
   PubMed Web of Science ®Google Scholar
• Ho JE, Lyass A, Lee DS, et al. Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction. Circ Heart Fail. 2013;6(2):279–286. doi:10.1161/CIRCHEARTFAILURE.112.972828
   PubMed Web of Science ®Google Scholar
• Chioncel O, Lainscak M, Seferovic PM, et al. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC heart failure long-term registry. Eur J Heart Fail. 2017;19(12):1574–1585. doi:10.1002/ejhf.813
   PubMed Web of Science ®Google Scholar
• Lofman I, Szummer K, Dahlstrom U, Jernberg T, Lund LH. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction. Eur J Heart Fail. 2017;19(12):1606–1614. doi:10.1002/ejhf.821
   PubMed Web of Science ®Google Scholar
• Wang H, Li YY, Chai K, et al. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China]. Zhonghua Xin Xue Guan Bing Za Zhi. 2019;47(11):865–874. Chinese. doi:10.3760/cma.j.issn.0253-3758.2019.11.004
   PubMedGoogle Scholar
• Shiga T, Suzuki A, Haruta S, et al. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan. ESC Heart Fail. 2019;6(3):475–486. doi:10.1002/ehf2.12418
   PubMed Web of Science ®Google Scholar
• Haass M, Kitzman DW, Anand IS, et al. Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in heart failure with preserved ejection fraction (I-PRESERVE) trial. Circ Heart Fail. 2011;4(3):324–331. doi:10.1161/CIRCHEARTFAILURE.110.959890
   PubMed Web of Science ®Google Scholar
• Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation. 1998;98(21):2282–2289. doi:10.1161/01.CIR.98.21.2282
   PubMed Web of Science ®Google Scholar
• Tadic M, Cuspidi C. Obesity and heart failure with preserved ejection fraction: a paradox or something else? Heart Fail Rev. 2019;24(3):379–385. doi:10.1007/s10741-018-09766-x
   PubMed Web of Science ®Google Scholar
• Neeland IJ, Gupta S, Ayers CR, et al. Relation of regional fat distribution to left ventricular structure and function. Circ Cardiovasc Imaging. 2013;6(5):800–807. doi:10.1161/CIRCIMAGING.113.000532
   PubMed Web of Science ®Google Scholar
• Simmonds SJ, Cuijpers I, Heymans S, Jones EAV. Cellular and molecular differences between HFpEF and HFrEF: a step ahead in an improved pathological understanding. Cells. 2020;9(1):242. doi:10.3390/cells9010242
   PubMed Web of Science ®Google Scholar
• Zile MR, Gottdiener JS, Hetzel SJ, et al. Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation. 2011;124(23):2491–2501. doi:10.1161/CIRCULATIONAHA.110.011031
   PubMed Web of Science ®Google Scholar
• Nauta JF, Hummel YM, Tromp J, et al. Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatment. Eur J Heart Fail. 2020;22(7):1147–1155. doi:10.1002/ejhf.1632
   PubMed Web of Science ®Google Scholar
• Savji N, Meijers WC, Bartz TM, et al. The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF. JACC Heart Fail. 2018;6(8):701–709. doi:10.1016/j.jchf.2018.05.018
   PubMed Web of Science ®Google Scholar
• Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355(3):251–259. doi:10.1056/NEJMoa052256
   PubMed Web of Science ®Google Scholar
• Tyrovolas S, El Bcheraoui C, Alghnam SA. The burden of disease in Saudi Arabia 1990–2017: results from the global burden of disease study 2017. Lancet Planet Health. 2020;4(5):e195–e208. doi:10.1016/S2542-5196(20)30075-9
   PubMedGoogle Scholar
• Oktay AA, Rich JD, Shah SJ. The emerging epidemic of heart failure with preserved ejection fraction. Curr Heart Fail Rep. 2013;10(4):401–410. doi:10.1007/s11897-013-0155-7
   PubMedGoogle Scholar
• Ozlek B, Ozlek E, Agus HZ, et al. Patients with HFpEF and HFmrEF have different clinical characteristics in Turkey: a multicenter observational study. Eur J Intern Med. 2019;61:88–95. doi:10.1016/j.ejim.2018.11.001
   PubMed Web of Science ®Google Scholar